Solana Company
NASDAQ:HSDTMedical - Devices
+$0.01 today
- Market cap
- $95.17M
- Beta
- 1.03
- P/E (TTM)
- -0.9
- EPS (TTM)
- -$1.78
Volume 0.23M
Average 0.38M
HSDT Income Tax Expense
Income taxes recognized for the period, including current and deferred tax.
Solana CompanyNASDAQ: HSDT
Income Tax Expense · Q1 FY2026 · quarter ended Mar 2026
Income tax expense remains negative
Q1 FY2026 income tax expense was $0, compared with $0 a year earlier. Trailing-twelve-month income tax expense was $0.
Context
- Income tax expense amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Income tax expense increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly income tax expense holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Income Tax Expense history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Income Tax Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Income Tax Expense vs competitors
How HSDT compares with its peers on the latest reported figures
- HSDT's LTM Mar 2026 income tax expense of $0 is the 7th highest of the 11 companies compared; the peer median is $46K.
- Income tax expense amounts to 0.0% of revenue for HSDT, versus a peer median of 1.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $3.88M | +13.3% | +229.2% | 2.7% | |
| LTM Mar 2026 | $3.47M | +41.9% | +58.3% | 4.8% | |
| LTM Mar 2026 | $820K | +84.7% | +34.5% | 0.7% | |
| LTM Mar 2026 | $237.15K | +652.3% | -3.7% | 1.3% | |
| LTM Mar 2026 | $86K | +218.5% | +250.3% | 0.2% | |
| LTM Mar 2026 | $6K | -25.0% | -8.0% | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | -$709K | -32.5% | — | 0.2% | |
| LTM Mar 2026 | -$793K | +63.3% | — | 128.3% | |
| LTM Dec 2025 | -$1.79M | -400.6% | — | 13.8% | |
| LTM Mar 2026 | -$2.22M | +16.7% | — | 1.5% | |
| Peer median (excluding HSDT) | $46K | +29.3% | +46.4% | 1.4% | |
Competitors are the stored peer set for HSDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 522K | 787K | 644K | 520K | 6.02M |
| Cost of Revenue | 298K | 463K | 583K | 582K | 500K |
| Gross Profit | 224K | 324K | 61K | (62K) | 5.52M |
| Gross Margin | 42.9% | 41.2% | 9.5% | -11.9% | 91.7% |
| Research & Development | 5.99M | 4.26M | 2.94M | 3.66M | 3.51M |
| Selling, General & Admin | 12.18M | 10.64M | 9.27M | 10.12M | 23.13M |
| Operating Expenses | 18.37M | 15.84M | 12.49M | 13.84M | 26.64M |
| Depreciation & Amortization | 312K | 255K | 162K | 60K | 680K |
| EBITDA | (17.82M) | (14.5M) | (12.11M) | (13.8M) | (39.58M) |
| EBITDA Margin | -3413.8% | -1842.9% | -1880.0% | -2654.4% | -657.7% |
| Operating Income | (18.14M) | (15.52M) | (12.43M) | (13.9M) | (21.12M) |
| Operating Margin | -3475.5% | -1971.5% | -1929.8% | -2673.7% | -351.0% |
| Interest Income | 0 | 0 | 257K | 0 | 0 |
| Interest Expense | 0 | 834K | 0 | 17K | 635K |
| Other Income / Expenses | 10K | 1.44M | 3.58M | 2.16M | (19.77M) |
| Income Before Tax | (18.13M) | (14.07M) | (8.85M) | (11.74M) | (40.89M) |
| Pre-Tax Margin | -3473.6% | -1788.1% | -1374.2% | -2258.1% | -679.6% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (18.13M) | (14.07M) | (8.85M) | (11.74M) | (40.89M) |
| Net Margin | -3473.6% | -1788.1% | -1374.2% | -2258.1% | -679.6% |
| EPS (Basic) | (184.51) | (26.06) | (7.28) | (4.33) | (1.85) |
| EPS (Diluted) | (184.51) | (26.06) | (7.28) | (4.33) | (1.85) |
| Weighted Avg Shares | 98.27K | 539.89K | 1.22M | 2.71M | 22.05M |
| Weighted Avg Shares (Diluted) | 98.27K | 539.89K | 1.22M | 2.71M | 22.05M |
Solana Company
NASDAQ:HSDT
Intrinsic Alpha fair value
Locked
Current Price
$1.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.